Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. Keeping that in mind, here are two stocks likely to meet or exceed Wall Street’s lofty expectations and one where consensus estimates seem disconnected from reality.
One Stock to Sell:
Vontier (VNT)
Consensus Price Target: $39.70 (29% implied return)
A spin-off of a spin-off, Vontier (NYSE: VNT) provides electronic products and systems to the transportation, automotive, and manufacturing sectors.
Why Do We Pass on VNT?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Forecasted revenue decline of 2.1% for the upcoming 12 months implies demand will fall off a cliff
- Earnings growth underperformed the sector average over the last five years as its EPS grew by just 1.2% annually
Vontier is trading at $30.78 per share, or 8.8x forward P/E. To fully understand why you should be careful with VNT, check out our full research report (it’s free).
Two Stocks to Buy:
Rocket Lab (RKLB)
Consensus Price Target: $114.33 (80% implied return)
Becoming the first private company in the Southern Hemisphere to reach space, Rocket Lab (NASDAQ: RKLB) offers rockets designed for launching small satellites.
Why Should You Buy RKLB?
- Annual revenue growth of 55.1% over the past two years was outstanding, reflecting market share gains this cycle
- Operating margin improvement of 111.4 percentage points over the last five years demonstrates its ability to scale efficiently
- Cash-burning tendencies have improved over the last five years, showing it could become financially independent one day
Rocket Lab’s stock price of $63.51 implies a valuation ratio of 39.2x forward price-to-sales. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
BGC (BGC)
Consensus Price Target: $15.50 (32.2% implied return)
Tracing its roots back to 1945 and named after founder Bernard Gerald Cantor, BGC Group (NASDAQ: BGC) operates a global brokerage and financial technology platform that facilitates trading across fixed income, foreign exchange, equities, energy, and commodities markets.
Why Do We Love BGC?
- Annual revenue growth of 24.8% over the last two years was superb and indicates its market share increased during this cycle
- Earnings per share grew by 24.6% annually over the last two years and trumped its peers
- ROE of 11.7% shows management can invest its resources competently
At $11.73 per share, BGC trades at 8.3x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
